Ultralow Dose PET Imaging for Alzheimer's and Dementia
Ultralow Dose PET Imaging of 18F-Florbetapir, 18F-Flutemetamol
Recruiting
Phase 2
Interventional Study
Alzheimer Disease
Mild Cognitive Impairment
Dementia
Healthy Volunteers
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 – 120
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 200 (estimated)
- Sponsor
- Akiva Mintz · Other
Who this trial is looking for
This trial is looking for adults to test a new imaging technique for Alzheimer's disease and other types of dementia. Participants will receive a small injection and then undergo imaging for up to 3 hours.
Are You a Good Fit for This Trial?
You may be able to join if
- I am at least 18 years old
- I can provide informed consent
- I am not pregnant or breastfeeding
- I have a negative pregnancy test if I can become pregnant
You may not be able to join if
- I have had too much radiation exposure from previous scans
- I have participated in this study more than four times
- I have severe claustrophobia or chronic pain
- I cannot provide informed consent
- I have any condition that may affect my safety in the study
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to evaluate an investigational ultralow dose Positron Emission Tomography (PET) imaging technique for Alzheimer's disease, mild cognitive impairment, other forms of dementia detection and monitoring. The main question it aims to answer is:
Can the investigators optimize the timing, scan duration, and image reconstruction to reduce the radiation dose 10-100 fold …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
Age ≥18 years; Ability to provide informed consent and comply with study procedures; For female participants: Must not be pregnant or breastfeeding; Negative pregnancy test required for women of childbearing potential.
Exclusion Criteria:
Participants who have exceeded NRC reg…
Contacts